Science · 1995 · 417 citations · 36 references
Life SciencesImmunologyMolecular BiologyCellular ImmunologyImmunotherapyTransplant ImmunologyGraft-versus-host DiseaseHistocompatibilityHistocompatibility AntigensHla MatchingHuman Leukocyte Antigen SystemMajor Histocompatibility ComplexClass I Histocompatibility AntigensGraft-versus-host Disease PathophysiologyHla Antigen MatchingHla Donor-recipient MatchingHla Matching In TransplantationHuman Leukocyte AntigensMinor Histocompatibility Antigen RecognitionStem Cell Donor Matching
Minor histocompatibility antigen disparities between HLA‑matched bone marrow donors and recipients are a major risk factor for graft‑versus‑host disease, as illustrated by a previously isolated HLA‑A2.1‑restricted cytotoxic T‑cell clone recognizing HA‑2 in a patient with severe GVHD. Because HA‑2 has a phenotype frequency of 95 % in the HLA‑A2.1‑positive population, it is a candidate for immunotherapeutic intervention in bone marrow transplantation. The HLA‑A2.1‑bound peptide representing HA‑2 has now been identified and appears to originate from a member of the non‑filament‑forming class I myosin family.
Minor histocompatibility antigen disparities between human leukocyte antigen (HLA)-matched bone marrow donors and recipients are a major risk factor for graft versus host disease (GVHD). An HLA-A2.1-restricted cytotoxic T cell clone that recognized the minor histocompatibility antigen HA-2 was previously isolated from a patient with severe GVHD after HLA-identical bone marrow transplantation. The HLA-A2.1-bound peptide representing HA-2 has now been identified. This peptide appears to originate from a member of the non-filament-forming class I myosin family. Because HA-2 has a phenotype frequency of 95 percent in the HLA-A2.1-positive population, it is a candidate for immunotherapeutic intervention in bone marrow transplantation.
36
Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
Kirsten Falk, Olaf Rötzschke, Stefan Stevanovié et al. · Nature · 1991 · 2.4K citations
Protein sequencing by tandem mass spectrometry.
Donald F. Hunt, John R. Yates, Jeffrey Shabanowitz et al. · Proceedings of the National Academy of Sciences · 1986 · 1.2K citations
Identification of a Peptide Recognized by Five Melanoma-Specific Human Cytotoxic T Cell Lines
Andrea L. Cox, Jonathan Skipper, Ye Chen et al. · Science · 1994 · 834 citations
Life Sciences, Immunology, Oncology +17
Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules
Jörg Ruppert, John Sidney, Esteban Celis et al. · Cell · 1993 · 632 citations